IDStewardship
DECEMBER 30, 2022
On this webpage the Learn Antibiotics book is described. Where Can I Find The Learn Antibiotics Book? The Learn Antibiotics Book is currently available on Amazon and can be found here. Beware there has been at least one fake listing of the book on Amazon, which has been flagged for removal.
PharmExec
DECEMBER 28, 2022
Top industry experts weigh in on what the new year holds for the pharma industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Phorum
DECEMBER 28, 2022
This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we near the end of the year, there were some big moves.
Pharmacy Times
DECEMBER 27, 2022
Develop New Year's resolutions that include empowering patients, enhancing communication, increasing professional development.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
IDStewardship
DECEMBER 26, 2022
In this article we do a quick run down on IDstewardship for the end of 2022. . Article Posted 26 December 2022. 2022 has come and gone in what seems like a flash. For IDstewardship it has been an exciting year of teaching and learning about the world of bugs and drugs.
Fierce Healthcare
DECEMBER 28, 2022
XBB COVID variant presents a unique threat: study. fdiamond. Wed, 12/28/2022 - 11:11
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
DECEMBER 30, 2022
This month's clinical pharmacology update looks at a medication to manage Helicobacter pylori infection in adults.
Fierce Pharma
DECEMBER 29, 2022
Biogen, FDA's inappropriate Aduhelm coordination detailed in blistering congressional report. aarmstrong. Thu, 12/29/2022 - 14:42
Pharmaceutical Technology
DECEMBER 27, 2022
The healthcare industry saw its share of ups and downs in 2022. Our response to the worldwide pandemic evolved over time, and so did the needs of the sector and the people relying on healthcare companies to deliver solutions.
Pharma Phorum
DECEMBER 30, 2022
Before getting lost in the vast options a decentralised clinical trial (DCT) setup provides, sponsors considering a DCT model need to keep in mind that it is not a one-size-fits-all approach.
Pharmacy Times
DECEMBER 27, 2022
First direct evidence of diminished 5-HT release proves hypothesis, according to a new analysis published in Biological Psychiatry.
Fierce Healthcare
DECEMBER 28, 2022
ACA exchange enrollment continues at record pace, nears 11.5M through mid-December. pminemyer. Wed, 12/28/2022 - 11:48
Pharmaceutical Commerce
DECEMBER 28, 2022
Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton.
Pharma Phorum
DECEMBER 30, 2022
The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to the community, according to a new survey of 200 GPs in the UK.
Pharmacy Times
DECEMBER 29, 2022
From newsworthy moments to groundbreaking research, these were the most-read articles on Pharmacy Times in 2022.
Fierce Pharma
DECEMBER 27, 2022
Roche gets FDA nod for Lunsumio, offering convenient option to gene therapies in follicular lymphoma. kdunleavy. Tue, 12/27/2022 - 09:16
Pharmaceutical Technology
DECEMBER 27, 2022
Indian pharmaceutical company Hetero has received the World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its Nirmacom (nirmatrelvir).
Pharma Phorum
DECEMBER 29, 2022
A new Data Protection and Digital Information Bill is currently being considered by UK ministers.
Pharmacy Times
DECEMBER 26, 2022
This year, retail pharmacists were interested in diabetes research, saving patients money, and influenza vaccine candidates.
Fierce Pharma
DECEMBER 29, 2022
After FDA's Ukoniq pull, TG Therapeutics wins commercial mulligan with Briumvi to enter crowded MS arena. fkansteiner. Thu, 12/29/2022 - 09:30
PharmExec
DECEMBER 30, 2022
AI continued to grow over the last year, and more life sciences companies are embracing the new technology in a variety of ways.
Pharma Phorum
DECEMBER 28, 2022
Gilead Sciences must like what it has seen in a two-year-old partnership with Jounce Therapeutics for a CCR8-targeting cancer immunotherapy – it has just agreed to take full ownership of the programme.
Pharmacy Times
DECEMBER 29, 2022
Products include a vaccine for meningococcal disease and a new type of COVID-19 test.
Pharmaceutical Commerce
DECEMBER 30, 2022
The latest people news happenings over the past month.
Fuld
DECEMBER 28, 2022
No one can predict the future, but you can build a strategic plan for it.
Pharma Phorum
DECEMBER 28, 2022
Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than for medical device sales teams, who typically schedule regular visits to hospitals and doctors’ offices to create a personal, ongoing connection that drives forward the sales process.
Pharmacy Times
DECEMBER 26, 2022
Without company or insurance contracts, controlled medication prices reduce burden on patients.
Fossil Remedies
DECEMBER 29, 2022
Since the pharma sector has performed remarkably well in the fast few decades and the future is also showing very good signs, it is quite natural that more and more people are entering the arena. There are many types of pharma businesses and one can choose any of them.
Fuld
DECEMBER 29, 2022
Social Media and Text Analytics. Leverage social media and NLP (natural language processing) analytics for applications in marketing and beyond. Marketing.
Pharma Phorum
DECEMBER 30, 2022
Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and what specifically had attracted Verheul to attend.
Pharmacy Times
DECEMBER 29, 2022
Both benefits and concerns exist, but implementing policies and regulations promotes employee productivity, guards safety.
InCrowd
DECEMBER 29, 2022
InCrowd conducted 2 surveys – one for Attending Physicians post-residency and one for Medical Residents for a total of 454 submissions for the Medical Residents and 209 responses collected from the Attending Physicians.
Fuld
DECEMBER 29, 2022
Competitive Intelligence Analytics. Track and stay ahead of your competition through automated KPI and news feeds visualized in dynamic dashboards. Company-specific data.
Pharma Phorum
DECEMBER 28, 2022
Biogen’s efforts to replenish its multiple sclerosis pipeline have suffered a setback, after the FDA placed a clinical hold on a drug candidate it licensed from China’s InnoCare last year for $125 million upfront. The US regulator has placed oral BTK inhibitor orelabrutinib on partial clinical hold, meaning new patients cannot be enrolled into clinical trials and patients treated with the drug for 70 days or less must discontinue treatment.
Pharmacy Times
DECEMBER 27, 2022
Cases address anticoagulants and medication administration.
PharmExec
DECEMBER 29, 2022
Personalized medicine continued its growth over the past year and became one of the most talked about topics in the life sciences industry.
Expert insights. Personalized for you.
130 
Let's personalize your content